Form 8-K - Current report:
SEC Accession No. 0001213900-25-015325
Filing Date
2025-02-19
Accepted
2025-02-19 16:49:11
Documents
15
Period of Report
2024-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0231620-8k_bespoke.htm   iXBRL 8-K 26721
2 AGREEMENT ea023162001ex10-1_bespoke.htm EX-10.1 8206
3 PROMISSORY NOTE ea023162001ex10-2_bespoke.htm EX-10.2 11240
  Complete submission text file 0001213900-25-015325.txt   220254

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20240219.xsd EX-101.SCH 3036
5 XBRL LABEL FILE bspk-20240219_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bspk-20240219_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0231620-8k_bespoke_htm.xml XML 3345
Mailing Address 12001 E. 33RD ST- UNIT O AURORA CO 80010
Business Address 12001 E. 33RD ST- UNIT O AURORA CO 80010 720-949-1143
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 25641237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)